本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Avidity Biosciences, Inc.

26.66
+0.90003.49%
盤後26.660.00000.00%17:37 EDT
成交量:153.00萬
成交額:4,056.76萬
市值:32.05億
市盈率:-9.23
高:27.02
開:25.77
低:25.66
收:25.76
資料載入中...
2020/12/21

重要事件披露

8-K - Current report
2020/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/07/27

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/16

重要事件披露

8-K - Current report
2020/06/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/11

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/11

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/26

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/22

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2015/02/12

非美公司披露報告